Title |
Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC
|
---|---|
Published in |
World Journal of Surgical Oncology, February 2017
|
DOI | 10.1186/s12957-016-1047-6 |
Pubmed ID | |
Authors |
Melissa L. Abel, George Kokosis, Dan G. Blazer |
Abstract |
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has become a common treatment approach for disseminated appendiceal neoplasms. Systemic absorption of intraperitoneal chemotherapeutics may lead to drug-induced toxicity, most commonly neutropenia. Mitomycin C has been the most commonly used chemotherapeutic in HIPEC for the past several decades. Here, we describe a rare pulmonary complication secondary to intraperitoneal administration of mitomycin C. While rare, intraperitoneal mitomycin C has the potential to cause serious pulmonary toxicity that should be considered with administration. To our knowledge, this report represents only the second case described in the literature. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 13 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 2 | 15% |
Student > Bachelor | 2 | 15% |
Unspecified | 1 | 8% |
Student > Doctoral Student | 1 | 8% |
Student > Ph. D. Student | 1 | 8% |
Other | 2 | 15% |
Unknown | 4 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 38% |
Nursing and Health Professions | 1 | 8% |
Unspecified | 1 | 8% |
Agricultural and Biological Sciences | 1 | 8% |
Computer Science | 1 | 8% |
Other | 0 | 0% |
Unknown | 4 | 31% |